BioRestorative Share Price

BioRestorative Share Price

NASDAQ: BRTX | Micro Cap | Healthcare
$1.29
+$1.29 (--%) Last updated on 20 Nov, 2026 | 01:04 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • FAQs

BioRestorative Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
$0.14 - $3.01
Volume
N/A
Average Traded
N/A

BioRestorative Share Price Chart

$0.00$0.00
L
Show Current Price
H

BioRestorative Stock Fundamentals & Key Indicators

Market Cap
$11.65M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-8.01
Revenue (TTM)
$360.00M
Return On Equity (TTM)
-365.43%
Profit Margin
-3955.56%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
19.17%

BioRestorative Quarterly Profit & Loss

All figures in USD

ParticularsJun 2025Sep 2025Dec 2025Mar 2026
Revenue$0.30$0.01$0.02$0.02
Net Profit-$2.66-$3.04-$3.21-$2.15
Net Profit Margin-886.67%-30400.00%-16050.00%-10750.00%
Income ChangeN/A-14.29%-5.59%33.02%

BioRestorative Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.12$0.15$0.40$0.36
Net Profit-$13.22-$10.42-$8.98-$14.24
Net Profit Margin-11016.67%-6946.67%-2245.00%-3955.56%
Income ChangeN/A21.18%13.82%-58.57%

BioRestorative Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets0.941.141.221.31
Current Assets3.1411.1411.3915.13
Total Assets4.0812.2812.6116.43
Non Current Liabilities0.00.00.00.16
Current Liabilities3.723.752.615.98
Total Liabilities3.723.752.616.14
Shareholders' Equity0.368.5310.010.29

BioRestorative Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-10.79-8.23-6.43-5.91
Investing8.90.513.25-13.4
Financing2.857.382.350.0

Corporate Actions

Split
Ex-date: 08 Sep 2026

Split
Ex-date: 27 Oct 2021

About BioRestorative

BioRestorative Therapies Inc is engaged in developing therapeutic products using cell and tissue protocols, involving adult stem cells. The company is pursuing its Disc/Spine Program with initial investigational therapeutic product being called BRTX-100 in the treatment of chronic cervical discogenic pain. The technology is an stem cell injection procedure that may offer relief from lower back pain, buttock and leg pain, and numbness and tingling in the leg and foot. It is also developing ThermoStem Program, a pre-clinical program which involves the use of brown adipose (fat) in connection with the cell-based treatment of type 2 diabetes and obesity as well as hypertension, other metabolic disorders and cardiac deficiencies.

BioRestorative Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.49
$1.29
-10.69%
Oct 2026
$2.42
$1.45
-37.77%
Sep 2026
$0.20
$2.33
+1,047.78%
Aug 2026
$0.21
$0.20
-0.98%
Jul 2026
$0.40
$0.20
-45.48%
Jun 2026
$0.43
$0.38
-17.54%
May 2026
$0.22
$0.46
+105.41%
Apr 2026
$0.27
$0.22
-19.27%
Mar 2026
$0.21
$0.28
+23.87%
Feb 2026
$1.17
$0.22
-79.82%
Jan 2026
$1.20
$1.10
-2.65%
Dec 2025
$1.06
$1.13
+9.18%

BioRestorative Share Price FAQs